These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34996067)

  • 81. Organ specific autoantibodies in preclinical and early clinical type 1 diabetes in Turkey.
    Erten G; Gurol AO; Deniz G; Satman I; Yilmaz MT
    Ups J Med Sci; 2007; 112(2):231-43. PubMed ID: 17578823
    [TBL] [Abstract][Full Text] [Related]  

  • 82. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
    Bosi E; Boulware DC; Becker DJ; Buckner JH; Geyer S; Gottlieb PA; Henderson C; Kinderman A; Sosenko JM; Steck AK; Bingley PJ;
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2881-2886. PubMed ID: 28531305
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prevalence of ZnT8 Antibody in Turkish Children and Adolescents with New Onset Type 1 Diabetes.
    Elmaoğulları S; Uçaktürk SA; Elbeg Ş; Döğer E; Tayfun M; Gürbüz F; Bideci A
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):108-112. PubMed ID: 28943512
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes.
    Brorsson CA; Pociot F;
    Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S8-13. PubMed ID: 26405073
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
    J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Autoantibodies to CCL3 are of low sensitivity and specificity for the diagnosis of type 1 diabetes.
    Huang G; Mo X; Li M; Xiang Y; Li X; Luo S; Zhou Z
    Acta Diabetol; 2012 Oct; 49(5):395-9. PubMed ID: 22350136
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Tissue transglutaminase autoantibodies in children with newly diagnosed type 1 diabetes are related to human leukocyte antigen but not to islet autoantibodies: A Swedish nationwide prospective population-based cohort study.
    Cerqueiro Bybrant M; Grahnquist L; Örtqvist E; Andersson C; Forsander G; Elding Larsson H; Lernmark Å; Ludvigsson J; Marcus C; Carlsson A; Ivarsson SA
    Autoimmunity; 2018 Aug; 51(5):221-227. PubMed ID: 30444426
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinical heterogeneity of type 1 diabetes (T1D) found in Asia.
    Park Y; Wintergerst KA; Zhou Z
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28544229
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
    Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
    Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Itoh Y; Hanafusa T
    J Diabetes Investig; 2021 Apr; 12(4):510-515. PubMed ID: 32696593
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes.
    Ekman I; Vuorinen T; Knip M; Veijola R; Toppari J; Hyöty H; Kinnunen T; Ilonen J; Lempainen J
    Pediatr Diabetes; 2019 Feb; 20(1):73-77. PubMed ID: 30338642
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort.
    Long AE; Gooneratne AT; Rokni S; Williams AJ; Bingley PJ
    J Clin Endocrinol Metab; 2012 Feb; 97(2):632-7. PubMed ID: 22162482
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.
    Steck AK; Johnson K; Barriga KJ; Miao D; Yu L; Hutton JC; Eisenbarth GS; Rewers MJ
    Diabetes Care; 2011 Jun; 34(6):1397-9. PubMed ID: 21562325
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes.
    Abdel-Latif M; Abdel-Moneim AA; El-Hefnawy MH; Khalil RG
    Clin Exp Immunol; 2017 Oct; 190(1):110-121. PubMed ID: 28640379
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes.
    Wyatt RC; Hagopian WA; Roep BO; Patel KA; Resnick B; Dobbs R; Hudson M; ; De Franco E; Ellard S; Flanagan SE; Hattersley AT; Oram RA; Johnson MB
    Diabetologia; 2022 Jul; 65(7):1179-1184. PubMed ID: 35501400
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation.
    Eason RJ; Thomas NJ; Hill AV; Knight BA; Carr A; Hattersley AT; McDonald TJ; Shields BM; Jones AG;
    Diabetes Care; 2022 Dec; 45(12):2844-2851. PubMed ID: 36205650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.